Brochure: Crystalline seeing is believing
Access crystallisation and formulation information at ml scale with the Crystalline series.
List view / Grid view
Access crystallisation and formulation information at ml scale with the Crystalline series.
Expanding solutions for challenging APIs through the coacervation process.
Size matters – particularly in competitive markets such as pharma and nutraceuticals due to its direct result on costs. Tradichems patented Hipering® process begins right at the start of the process chain by miniaturizing the ingredients. Thanks to Piab’s piFLOW®p vacuum conveyor their patented process is continuously fed thus maintaining…
MMTS Mini tabs delivers child-friendly, broad-range dosing for toddlers.
The solubility of a compound in organic solvents or water is equally important for screen design and later for process development.
Automated endotoxin testing is achieved in a compact platform, leveraging microfluidic liquid handling. QC labs simplify BET with easier, compliant assays using less LAL.
How to turn an older refrigeration system in an existing freeze-dryer into a new environmentally friendly cooling system.
This whitepaper discusses the analytical testing considerations for complex biological materials in ATMPs.
Improve and accelerate your crystallisation screening with the Crystal16 parallel crystalliser.
Microcaps exceeds stringent requirements beyond taste masking.
Save time with the feedback control option at the Crystal16 and the CrystalBreeder. Simplify crystallisation by automating your process.
Case study example regarding finding impurities and controlling formations at release.
The course of drug development rarely does run smooth. Here, Dave Elder considers how sourcing key excipients impacts the process, highlighting potential consequences of a dual sourcing strategy and suggesting how to approach problems of inter-supplier variability.
Challenges and solutions to adopting MALDI technology for filamentous fungi ID with emphasis on sample preparation and database development.
The journey from large molecule to approved biotherapeutic is long, costly, complex, and fraught with risk – yet rewards for success are substantial.